Doubleview Gold Corp. Highlights Scandium Potential at Hat Project, a Key Enabler for the Electrification EconomyNovember 20, 2025 9:00 AM EST | Source: Doubleview Gold Corp.Vancouver, British Columbia--(Newsfile Corp. - November 20, 2025) - Doubleview Gold Corp. (TSXV: DBG) (OTCQB: DBLVF) (FSE: 1D4) ("Doubleview" or the "Company"), is a leading Canadian exploration company that is currently finalizing a Preliminary Economic Assessment (PEA) and updated Preliminary Resource Estimate (MRE) at i ...

Core Insights - Hemostemix Inc. is advancing ACP-01, an autologous stem cell therapy, for the treatment of vascular dementia, with Dr. William R. Shankle leading the Phase I clinical trial [1][8][10] Company Overview - Hemostemix Inc. specializes in autologous stem cell therapies, particularly VesCell™ (ACP-01), targeting various conditions including vascular dementia, chronic limb threatening ischemia, and congestive heart failure [1][12] - The company has completed seven clinical studies involving 318 subjects and has published results in eleven peer-reviewed publications [12] Clinical Trial Details - The Phase I clinical trial protocol for ACP-01 has been submitted to an Institutional Review Board (IRB) for ethical review, with revisions made based on initial comments [9][10] - Dr. Shankle is reviewing a patient database of approximately 500 individuals diagnosed with cognitive impairment to identify up to 30 patients for the trial [10] Dr. William R. Shankle's Background - Dr. Shankle has over 35 years of medical practice, focusing on cognitive disorders and has been involved in numerous clinical programs and public education initiatives [2][3] - He is the founder of The Shankle Clinic and has held leadership roles at the University of California, Irvine, contributing to advancements in the understanding of vascular dementia [3][4] ACP-01 and Vascular Dementia - ACP-01 is designed to promote angiogenesis and microvascular repair, addressing the vascular underpinnings of vascular dementia [5][8] - The therapy has shown safety and clinical relevance in treating other conditions, with significant outcomes reported in previous studies [12]

Core Insights - The FUTR Corporation has entered a national channel partnership with Tax Max, significantly expanding its automotive retail network by approximately 400% [1][2][3] - The partnership aims to introduce FUTR's bi-weekly auto loan payment solution to Tax Max's extensive network of dealerships across the U.S., enhancing customer satisfaction and reducing delinquencies [2][3] Company Overview - FUTR is an AI-powered consumer finance platform that allows users to manage and spend the value of their data [1][6] - The company recently launched Payments 2.0, a modern auto payments platform designed to facilitate quick onboarding for dealers [3] Partnership Details - Under the multi-year agreement, Tax Max will be the exclusive channel partner for FUTR's vehicle payment plan products within its tax and dealer service network [2][4] - The partnership is expected to run for an initial period of 36 months, with plans for future expansion as FUTR integrates more dealers and lenders [4] Tax Max Overview - Tax Max is a leading provider of tax and financial services for the automotive industry, supporting thousands of dealerships across the U.S. [7][9] - The company offers innovative programs to help dealerships optimize their operations during tax season, enhancing sales and customer experience [8][9]

Core Insights - Intelligent Bio Solutions Inc. will participate in the 21st Annual Emerging Growth Equity Conference hosted by Noble Capital Markets on December 2-3, 2025 [1] Company Overview - Intelligent Bio Solutions Inc. is a medical technology company focused on delivering intelligent, rapid, non-invasive testing solutions [4] - The company’s Intelligent Fingerprinting Drug Screening System utilizes fingerprint sweat analysis, aiming to revolutionize portable testing with potential applications in various fields [4] - The system is designed to be hygienic and cost-effective, screening for recent drug use, including opiates, cocaine, methamphetamine, and cannabis, with results available in under ten minutes [4] - Current customer segments outside the U.S. include construction, manufacturing, engineering, transport and logistics, mining, drug treatment organizations, and coroners [4] Conference Details - The conference will take place at Florida Atlantic University, Boca Raton, FL, with Intelligent Bio Solutions scheduled to present on December 3, 2025, at 11:00 a.m. Eastern Time [2] - A webcast recording of the presentation will be available on the company's investor relations website and Noble's website for 90 days post-event [2]

Core Insights - Forge Resources Corp. has reported significant gold assay results from its Alotta Project, with a notable intercept of 45.01 g/tonne gold over a core length of 3.15 meters starting at 286.0 meters depth [1][4][6] Summary by Sections Gold Assay Results - The assay results from drill hole ALT-25-012 indicate high-grade gold mineralization, including 58.93 g/tonne over 2.4 meters and 105 g/tonne over 1.25 meters [4][6] - The company has completed the first batch of gold assays, with multi-element analysis results still pending [2][4] Drilling Program - A total of 1262.75 meters of drilling was completed in four drill holes during the Phase 2 drill program in 2025 [9] - The mineralization at Alotta is confirmed to be open in all directions, with a mineralized footprint of approximately 4 km by 1 km [6] Geological Context - The Alotta Project is characterized as a gold-enriched porphyry system, hosting semi-massive polymetallic sulphide veins and quartz veins [6][26] - The first 80 meters of drill hole ALT-25-012 contains numerous veins, with assay results still pending [6] Company Overview - Forge Resources Corp. is a Canadian junior exploration company focused on the Alotta project, which consists of 230 mineral claims covering approximately 4,723 hectares [26] - The Alotta property is located 50 km southeast of the Casino porphyry deposit, one of the largest undeveloped gold-copper porphyry projects globally [23][26]

Core Viewpoint - Northern Graphite Corporation has placed its Lac des Iles mine and mill into temporary care and maintenance to address an unexpected equipment issue and to expedite maintenance and development work ahead of the 2026 pit expansion [1][2]. Company Update - The decision for care and maintenance was driven by a bearing failure at the mill, which has a replacement window of approximately four to six weeks [2]. - The company has ordered a replacement part and is advancing other maintenance projects that were originally scheduled for January [2][3]. - The Lac des Iles mine produces approximately 15,000 tonnes of graphite concentrate per year, with an installed capacity of 25,000 tonnes per year [4]. Expansion Plans - Pre-stripping activity is currently underway as part of Phase 1 of an expansion program that could potentially add eight years to the mine life [4]. - The expansion program is being partially financed by Natural Resources Canada, covering 75% of eligible costs up to $6.2 million [4]. - The company is in the final stages of applying for a Certificate of Authorization from Quebec's environmental ministry to mine to 203 meters above sea level, with production from the expanded pit anticipated to start in the second quarter of next year [5]. Regulatory and Operational Status - The company is currently authorized to mine to 209 meters, but has temporarily halted operations after inadvertently mining slightly below this depth [6]. - A minor amendment to the existing Certificate of Authorization will be requested to allow mining to continue at the current pit to 203 meters [6]. - This situation may result in a production gap of approximately two to three months between existing operations and production from the expanded pit [6]. Strategic Importance - The company aims to extend the life of the Lac des Iles mine, which is considered a strategic asset for creating a secure and sustainable North American supply chain for graphite, critical for the growing battery markets [7][8]. - Northern Graphite is focused on becoming a world leader in producing natural graphite and upgrading it into high-value products for the green economy, including materials for lithium-ion batteries and other advanced technologies [8].

Core Insights - OneMeta Inc. reported significant year-over-year revenue growth in Q3 2025, with total revenue reaching $474,604 compared to $3,478 in the same period last year, while also reducing its net loss to $827,480 from $935,353 in Q3 2024 [3][4]. Financial Performance - Revenue for Q3 2025 was $474,604, a substantial increase from $3,478 in Q3 2024 [3]. - The net loss improved to $827,480 from $935,353 in the same quarter of the previous year [3]. Strategic Focus - The company emphasized disciplined growth and prudent expense management, which contributed to the narrowing of net loss [2][3]. - OneMeta is focusing on product innovation and customer success to position itself for sustainable long-term growth in the multilingual communication sector [3][6]. Product Development - OneMeta launched two new products, VerbumAgentis™ and VerbumLocal™, enhancing its real-time AI multilingual suite [4][5]. - VerbumAgentis enables live, simultaneous bidirectional voice translation across 140+ languages, while VerbumLocal provides on-device interpretation in secure environments [5]. Market Engagement - Growth was driven by new enterprise and government customer engagements, with deployments initiated during the quarter [4]. - The company is prioritizing tailored enterprise solutions to meet increasing demand across various industries, including healthcare, finance, education, and government [6].

Core Insights - Envoy Medical has secured a new U.S. patent for an innovative cochlear implant system that features a removable earplug sensor and an implanted battery, reinforcing its leadership in next-generation cochlear implant technology [1][2][3] Company Developments - The newly granted patent, titled "Combination Implant System with Removable Earplug Sensor and Implanted Battery," enhances Envoy Medical's intellectual property portfolio and covers systems that include an implantable subsystem with a stimulator and rechargeable energy storage [2][3] - The patent supports the company's long-term innovation strategy and aims to protect future advancements in implanted technologies, not just current devices [3] - Envoy Medical is making positive progress in its pivotal Acclaim® Cochlear Implant clinical trial, which has received Breakthrough Device Designation from the FDA in 2019 [3][4][8] Product Information - The Acclaim Cochlear Implant is designed for individuals with severe to profound sensorineural hearing loss and utilizes a sensor that leverages the natural anatomy of the ear instead of a microphone [7][8] - The Esteem® fully implanted active middle ear implant is another innovative product from Envoy Medical, which has been commercially available in the U.S. since 2010 and allows for continuous hearing without external components [5][9]

Core Insights - Blue Star Gold Corp. has expanded its Roma Project to include the Sand Lake prospect, which is identified as a high-potential, copper-rich volcanogenic massive sulphide (VMS) target with significant historical drill results [1][3][6] Summary by Sections Sand Lake Prospect - The newly acquired ground is part of an expanded Roma Mineral Exploration Agreement (MEA) and includes historical drill results of 21 meters averaging 2.71% copper and 15 meters of 3.29% copper, indicating a promising mineralization zone typical of VMS systems [3][6] - Previous operators also identified a zinc-rich zone greater than 10 meters wide in the northernmost Sand Lake drill section [3] Geological Context - VMS deposits typically occur in clusters within favorable volcanic belts, and the Sand Lake prospect is located 5 km east of Blue Star's recent Ataani VMS discovery, suggesting it may be part of the broader High Lake VMS camp [4][6] Infrastructure and Logistics - The expanded Sand Lake tenure includes a ~400 m sand airstrip on flat terrain, which is advantageous for future exploration and infrastructure development [5][6] - Existing infrastructure includes a 40-person Ulu camp and a ~1,350 m gravel airstrip suitable for C-130 Hercules aircraft, located approximately 75 km south of Sand Lake, enhancing operational capabilities [5][6] Future Plans - Blue Star plans to incorporate the Sand Lake prospect into its 2026 exploration program, which will involve geological mapping, ground geophysics, and target refinement in preparation for potential follow-up drilling [7]

Core Viewpoint - Tartisan Nickel Corp. has engaged Rodren Drilling Ltd. to conduct a drill program at its Kenbridge Nickel-Copper-Cobalt Deposit, aiming to advance the project towards an updated Mineral Resource Estimate and a Pre-Feasibility Study [1][2][3] Company Overview - Tartisan Nickel Corp. is a Canadian-based exploration and development company focused on critical metals, owning the Kenbridge Nickel Project, Night Danger Turtle Pond project, and Sill Lake Silver Property [4] Drill Program Details - The Phase 1 drill program will involve 3600 meters of diamond drilling across priority targets, focusing on converting Inferred resources into Measured and Indicated categories and exploring potential extensions of high-grade Ni-Cu mineralization at depth [2][8] - Mobilization to the Kenbridge site is scheduled for December 2025 [8] Contractor Engagement - The company has retained Rodren Drilling Ltd., a respected contractor with significant experience in Ontario's mining districts, marking an important milestone in advancing the Kenbridge project [3]